HNRNPH3 expression based on
KICH : Kidney chromophobe Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
Comparison Statistical significance Normal-vs-Primary 4.95260499278061E-11
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
KICH : Kidney chromophobe Note
Cancer stage information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.35630412351406E-11
Normal-vs-Stage2
6.74169609027331E-11
Normal-vs-Stage3
1.2767999990615E-09
Normal-vs-Stage4
4.26339999970438E-08
Stage1-vs-Stage2
6.200400E-01
Stage1-vs-Stage3
4.551400E-01
Stage1-vs-Stage4
1.836580E-01
Stage2-vs-Stage3
2.600600E-01
Stage2-vs-Stage4
3.906400E-01
Stage3-vs-Stage4
1.074410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
KICH : Kidney chromophobe Note
Patient race information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.31129576483613E-11
Normal-vs-AfricanAmerican
4.02380018194037E-10
Normal-vs-Asian
1.296120E-02
Caucasian-vs-AfricanAmerican
7.796200E-01
Caucasian-vs-Asian
6.032000E-01
AfricanAmerican-vs-Asian
2.793400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
KICH : Kidney chromophobe Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.26390017843414E-11
Normal-vs-Female
6.84480250257025E-11
Male-vs-Female
4.891800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
KICH : Kidney chromophobe Note
Patient age information is not available for 1 sample and one sample from patient below 21 years not considered in above plot.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.07929998272027E-10
Normal-vs-Age(41-60Yrs)
2.05609973491505E-11
Normal-vs-Age(61-80Yrs)
9.80479997192418E-09
Normal-vs-Age(81-100Yrs)
N/A
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.889000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.539400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
N/A
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.943800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
N/A
Age(61-80Yrs)-vs-Age(81-100Yrs)
N/A
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
KICH : Kidney chromophobe Note
Cancer in nearby lymph nodes cannot be measured (NX) in 21 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.69388980409258E-12
Normal-vs-N1
1.821010E-03
Normal-vs-N2
1.814200E-02
N0-vs-N1
5.597000E-01
N0-vs-N2
2.107000E-01
N1-vs-N2
6.855200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
KICH : Kidney chromophobe Note
Whole exome sequencing data is not available for 1 sample.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.6156968792086E-11
Normal-vs-TP53-NonMutant
4.96850338649324E-11
TP53-Mutant-vs-TP53-NonMutant
8.854400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
